التفاصيل البيبلوغرافية
| العنوان: |
One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry |
| المؤلفون: |
Harrold, Leslie R., Litman, Heather J., Saunders, Katherine C., Dandreo, Kimberly J., Gershenson, Bernice, Greenberg, Jeffrey D., Low, Robert, Stark, Jeffrey, Suruki, Robert, Jaganathan, Srihari, Kremer, Joel M., Yassine, Mohamed |
| المساهمون: |
UCB Pharma, Corrona, LLC |
| المصدر: |
Arthritis Research & Therapy ; volume 20, issue 1 ; ISSN 1478-6362 |
| بيانات النشر: |
Springer Science and Business Media LLC |
| سنة النشر: |
2018 |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1186/s13075-017-1496-5 |
| DOI: |
10.1186/s13075-017-1496-5.pdf |
| الإتاحة: |
https://doi.org/10.1186/s13075-017-1496-5Test |
| رقم الانضمام: |
edsbas.E8727255 |
| قاعدة البيانات: |
BASE |
